Peptides DB
Research-centric peptide and protocol reference hub
Study 37 of 37NAD+ (Nicotinamide Adenine Dinucleotide) literaturePlatelets · Observational2026

The mitochondrial deacetylase SIRT3 is nonessential for cyclophilin D-dependent procoagulant platelet formation in mice.

SIRT3 is not required for procoagulant platelet formation, indicating that platelets may rely on different mechanisms for activation.

Read at PlateletsAdd to compare

Where it sits

this study against the rest of the nad+ (nicotinamide adenine dinucleotide) corpus
17
Preclinical
15
Observational · this one
0
Open-label
1
Randomised
4
Reviews

Summary and findings

This study investigated the role of SIRT3 in procoagulant platelet formation using platelets from Sirt3 knockout mice and littermate controls. The findings indicated that SIRT3 does not alter mitochondrial respiration or procoagulant platelet generation in response to agonist stimulation. No specific dose was reported.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as Platelets supplied them

Sirtuin 3 (SIRT3) is a nicotinamide adenine dinucleotide (NAD)-dependent mitochondrial deacetylase that regulates protein acetylation and maintains mitochondrial homeostasis in nucleated cells. By deacetylating cyclophilin D (CypD), SIRT3 limits mitochondrial permeability transition pore (mPTP) opening and protects against mitochondrial dysfunction. Although SIRT3 is present in murine and human platelets, its contribution to platelet mitochondrial regulation and procoagulant platelet formation remains unknown. This study investigated whether platelet SIRT3 modulates CypD-dependent procoagulant platelet formation. Platelets obtained from platelet-specific Sirt3 knockout mice (<i>Sirt3</i><sup><i>plt-/-</i></sup>) and littermate controls (<i>Sirt3</i><sup><i>plt+/+</i></sup>) were analyzed under resting conditions and after activation with CRP-XL and thrombin. Flow cytometry was used to analyze platelet (activation) markers and procoagulant platelet formation, and mitochondrial respiration was assessed using a Seahorse extracellular flux analyzer. Platelets lacking SIRT3 showed no alterations in basal or agonist-stimulated mitochondrial respiration. Likewise, platelet <i>Sirt3</i> deletion did not affect the generation of procoagulant platelets in response to strong dual agonist stimulation. These findings indicate that, despite its role in regulating mPTP opening in nucleated cells, platelet SIRT3 is not required for procoagulant platelet formation, suggesting that platelets rely on distinct mechanisms for mPTP regulation.

Background

The paper addresses the role of SIRT3, a NAD-dependent mitochondrial deacetylase, in regulating procoagulant platelet formation. Prior knowledge indicated that SIRT3 influences mitochondrial function and permeability transition pore (mPTP) opening in nucleated cells. Understanding its role in platelets is significant due to the implications for coagulation processes.

Methods

The study utilized platelet-specific Sirt3 knockout mice and littermate controls to analyze platelet function. Flow cytometry assessed platelet activation markers and procoagulant formation, while mitochondrial respiration was measured using a Seahorse extracellular flux analyzer. Specific agonists CRP-XL and thrombin were used for platelet activation.

Results

The primary endpoint indicated that platelets lacking SIRT3 showed no alterations in basal or agonist-stimulated mitochondrial respiration. Additionally, Sirt3 deletion did not affect procoagulant platelet generation in response to dual agonist stimulation.

Interpretation

These findings suggest that SIRT3 does not play a critical role in procoagulant platelet formation, contrasting with its established function in nucleated cells. The lack of significant changes in mitochondrial respiration and procoagulant formation raises questions about the mechanisms platelets use for mPTP regulation. The study's reliance on murine models may limit the applicability of these results to human physiology.

Key findings

  • Platelets lacking SIRT3 showed no alterations in basal or agonist-stimulated mitochondrial respiration.
  • Sirt3 deletion did not affect the generation of procoagulant platelets in response to strong dual agonist stimulation.

Limitations

  • Focus on murine models, which may not fully translate to human physiology.
  • Small sample size not specified in abstract.
  • Single-site study limits generalizability.

Elsewhere in the NAD+ (Nicotinamide Adenine Dinucleotide) corpus

DA comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.Journal of enzyme inhibition and medicinal chemistry · 2026 · 31 of 46 FDA-approved drugs in 2025 were small molecule drugs.reviewCNicotinamide-derived tumor-targeting carbon dots for Cancer Photothermal therapy.Journal of colloid and interface science · 2026 · Binding energy of NAM-CDs to Ki67 was -7.7 kcal/mol.AnimalCMitochondrial-targeted nano-enhancer driving a self-amplifying NAD&lt;sup&gt;+&lt;/sup&gt; feedback loop to reprogram MSC spheroids metabolism for accelerated bone regeneration.Biomaterials · 2026In vitroDPyridoxal photoenzymes for asymmetric radical-radical cross-couplings.Nature · 2026CPhage anti-defense genes targeting NAD&lt;sup&gt;+&lt;/sup&gt; metabolism and DNA replication are associated with a broad host range against &lt;i&gt;Klebsiella pneumoniae&lt;/i&gt;.Virulence · 2026 · Not reported in abstract.AnimalCMitogenomic characterisation of non-native freshwater snails in Australia: Implications for biosecurity and trematode vector surveillance.One health (Amsterdam, Netherlands) · 2026 · Genome sizes ranged from 13.7 to 14.3 kb.Animal